TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2017
|
| In: |
OncoTarget
Year: 2017, Jahrgang: 8, Heft: 11, Pages: 18381-18398 |
| ISSN: | 1949-2553 |
| DOI: | 10.18632/oncotarget.15110 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: http://dx.doi.org/10.18632/oncotarget.15110
|
| Verfasserangaben: | Rainer Fagerholm, Sofia Khan, Marjanka K. Schmidt, Montserrat García- Closas, Päivi Heikkilä, Jani Saarela, Jonathan Beesley, Maral Jamshidi , Kristiina Aittomäki, Jianjun Liu, H. Raza Ali, Irene L. Andrulis, Matthias W. Beckmann, Sabine Behrens, Fiona M. Blows, Hermann Brenner, Jenny Chang-Claude, Fergus J. Couch, Kamila Czene, Peter A. Fasching, Jonine Figueroa, Giuseppe Floris, Gord Glendon, Qi Guo, Per Hall, Emily Hallberg, Ute Hamann, Bernd Holleczek, Maartje J. Hooning, John L. Hopper, Agnes Jager, Maria Kabisch, kConFab/AOCS Investigators, Renske Keeman, Veli-Matti Kosma, Diether Lambrechts, Annika Lindblom, Arto Mannermaa, Sara Margolin, Elena Provenzano, Mitul Shah, Melissa C. Southey, Joe Dennis , Michael Lush, Kyriaki Michailidou, Qin Wang, Manjeet K. Bolla, Alison M. Dunning, Douglas F. Easton, Paul D.P. Pharoah, Georgia Chenevix-Trench, Carl Blomqvist, and Heli Nevanlinna |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1557024278 | ||
| 003 | DE-627 | ||
| 005 | 20220813163157.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 170427s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.18632/oncotarget.15110 |2 doi | |
| 035 | |a (DE-627)1557024278 | ||
| 035 | |a (DE-576)487024273 | ||
| 035 | |a (DE-599)BSZ487024273 | ||
| 035 | |a (OCoLC)1340973257 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Fagerholm, Rainer |e VerfasserIn |0 (DE-588)1130810690 |0 (DE-627)885200713 |0 (DE-576)48702365X |4 aut | |
| 245 | 1 | 0 | |a TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer |c Rainer Fagerholm, Sofia Khan, Marjanka K. Schmidt, Montserrat García- Closas, Päivi Heikkilä, Jani Saarela, Jonathan Beesley, Maral Jamshidi , Kristiina Aittomäki, Jianjun Liu, H. Raza Ali, Irene L. Andrulis, Matthias W. Beckmann, Sabine Behrens, Fiona M. Blows, Hermann Brenner, Jenny Chang-Claude, Fergus J. Couch, Kamila Czene, Peter A. Fasching, Jonine Figueroa, Giuseppe Floris, Gord Glendon, Qi Guo, Per Hall, Emily Hallberg, Ute Hamann, Bernd Holleczek, Maartje J. Hooning, John L. Hopper, Agnes Jager, Maria Kabisch, kConFab/AOCS Investigators, Renske Keeman, Veli-Matti Kosma, Diether Lambrechts, Annika Lindblom, Arto Mannermaa, Sara Margolin, Elena Provenzano, Mitul Shah, Melissa C. Southey, Joe Dennis , Michael Lush, Kyriaki Michailidou, Qin Wang, Manjeet K. Bolla, Alison M. Dunning, Douglas F. Easton, Paul D.P. Pharoah, Georgia Chenevix-Trench, Carl Blomqvist, and Heli Nevanlinna |
| 264 | 1 | |c 2017 | |
| 300 | |a 18 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 27.04.2017 | ||
| 700 | 1 | |a Brenner, Hermann |e VerfasserIn |0 (DE-588)1020516445 |0 (DE-627)691247005 |0 (DE-576)360642136 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t OncoTarget |d [Erscheinungsort nicht ermittelbar] : Impact Journals LLC, 2010 |g 8(2017), 11, Seite 18381-18398 |h Online-Ressource |w (DE-627)63035975X |w (DE-600)2560162-3 |w (DE-576)325343764 |x 1949-2553 |7 nnas |a TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer |
| 773 | 1 | 8 | |g volume:8 |g year:2017 |g number:11 |g pages:18381-18398 |g extent:18 |a TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer |
| 856 | 4 | 0 | |u http://dx.doi.org/10.18632/oncotarget.15110 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20170427 | ||
| 993 | |a Article | ||
| 994 | |a 2017 | ||
| 998 | |g 1020516445 |a Brenner, Hermann |m 1020516445:Brenner, Hermann |d 850000 |d 851600 |d 50000 |e 850000PB1020516445 |e 851600PB1020516445 |e 50000PB1020516445 |k 0/850000/ |k 1/850000/851600/ |k 0/50000/ |p 16 | ||
| 999 | |a KXP-PPN1557024278 |e 2966946091 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"note":["Gesehen am 27.04.2017"],"recId":"1557024278","name":{"displayForm":["Rainer Fagerholm, Sofia Khan, Marjanka K. Schmidt, Montserrat García- Closas, Päivi Heikkilä, Jani Saarela, Jonathan Beesley, Maral Jamshidi , Kristiina Aittomäki, Jianjun Liu, H. Raza Ali, Irene L. Andrulis, Matthias W. Beckmann, Sabine Behrens, Fiona M. Blows, Hermann Brenner, Jenny Chang-Claude, Fergus J. Couch, Kamila Czene, Peter A. Fasching, Jonine Figueroa, Giuseppe Floris, Gord Glendon, Qi Guo, Per Hall, Emily Hallberg, Ute Hamann, Bernd Holleczek, Maartje J. Hooning, John L. Hopper, Agnes Jager, Maria Kabisch, kConFab/AOCS Investigators, Renske Keeman, Veli-Matti Kosma, Diether Lambrechts, Annika Lindblom, Arto Mannermaa, Sara Margolin, Elena Provenzano, Mitul Shah, Melissa C. Southey, Joe Dennis , Michael Lush, Kyriaki Michailidou, Qin Wang, Manjeet K. Bolla, Alison M. Dunning, Douglas F. Easton, Paul D.P. Pharoah, Georgia Chenevix-Trench, Carl Blomqvist, and Heli Nevanlinna"]},"origin":[{"dateIssuedDisp":"2017","dateIssuedKey":"2017"}],"id":{"doi":["10.18632/oncotarget.15110"],"eki":["1557024278"]},"language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"relHost":[{"recId":"63035975X","pubHistory":["1.2010,Mai -"],"note":["Gesehen am 16.08.2018"],"disp":"TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancerOncoTarget","part":{"text":"8(2017), 11, Seite 18381-18398","pages":"18381-18398","volume":"8","issue":"11","extent":"18","year":"2017"},"title":[{"title_sort":"OncoTarget","subtitle":"open access impact journal","title":"OncoTarget"}],"physDesc":[{"extent":"Online-Ressource"}],"language":["eng"],"id":{"issn":["1949-2553"],"zdb":["2560162-3"],"eki":["63035975X"]},"type":{"media":"Online-Ressource","bibl":"periodical"},"origin":[{"dateIssuedDisp":"2010-","publisherPlace":"[Erscheinungsort nicht ermittelbar]","dateIssuedKey":"2010","publisher":"Impact Journals LLC"}]}],"title":[{"title":"TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer","title_sort":"TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer"}],"person":[{"given":"Rainer","family":"Fagerholm","display":"Fagerholm, Rainer","role":"aut"},{"role":"aut","display":"Brenner, Hermann","family":"Brenner","given":"Hermann"}],"physDesc":[{"extent":"18 S."}]} | ||
| SRT | |a FAGERHOLMRTP53BASEDI2017 | ||